Vaxcyte, Inc. (PCVX) Executive Compensation
Vaxcyte, Inc. (PCVX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PCVX
CIK: 1649094
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerKelsey Yuan
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-09 | 2026-10-06 | 8-K | 0001193125-26-419174 | View SEC Doc Filr Page |
| 424B5 | 2026-10-08 | — | 424B5 | 0001193125-26-417984 | View SEC Doc Filr Page |
| 424B5 | 2026-10-08 | — | 424B5 | 0001193125-26-417977 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001813798-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001960048-26-000013 | View SEC Doc Filr Page |
| FWP | 2026-10-07 | — | FWP | 0001193125-26-416132 | View SEC Doc Filr Page |
| 305B2 | 2026-10-06 | — | 305B2 | 0001193125-26-414780 | View SEC Doc Filr Page |
| 424B5 | 2026-10-06 | — | 424B5 | 0001193125-26-414774 | View SEC Doc Filr Page |
| 424B5 | 2026-10-06 | — | 424B5 | 0001193125-26-414772 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001969223-26-001059 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001969223-26-001058 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001193125-26-413168 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001813798-26-000021 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001969223-26-001049 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001258693-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001230724-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001886794-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001960048-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001813798-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0002151661-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-09-09 | 2026-08-31 | FORM 3 | 0002151661-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001969223-26-001012 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001969223-26-001001 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-08-31 | 8-K | 0001649094-26-000045 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001813798-26-000017 | View SEC Doc Filr Page |